The Competitive Strategy Study Of A Pharmaceutical Company

Pharmaceutical industry,especially multinational pharmaceutical company is a key player of Gross National Product(GDP)in China's economy;especially it is Also related to the people's health,living quality,and social stability.Multinational pharmaceutical company development in China had made great contribution to improve the quality of medical service.The homogeneity of its business in All pharmaceutical companies and the developmental level of a multinational pharmaceutical company makes the study of a multinational pharmaceutical company's competition strategy has certain reference significance to the choices of others.According to the qualitative methods,and taken a multinational pharmaceutical company as research object,this paper analyzed the macro environment,external industrial environment,the strategic resources and capabilities,As well As the advantages and disadvantages of a multinational pharmaceutical company through the tools of PEST analysis,Porter's five forces analysis model,Barney's VRIO framework analysis and SWOT analysis model.Based on the above analysis,this paper puts forward the strategic choice of A multinational pharmaceutical company,including strategic positioning,objectives,vision And development measures,which might bring some insights for a multinational pharmaceutical company's future development,as well as other companies in the medical industry.